This report contains market size and forecasts of Novel Oral Anticoagulants Drugs in global, including the following market information:
- Global Novel Oral Anticoagulants Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Novel Oral Anticoagulants Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Novel Oral Anticoagulants Drugs companies in 2021 (%)
The global Novel Oral Anticoagulants Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Direct Thrombin Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Novel Oral Anticoagulants Drugs include Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Boehringer Ingelheim and Daiichi Sankyo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Novel Oral Anticoagulants Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Oral Anticoagulants Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Novel Oral Anticoagulants Drugs Market Segment Percentages, by Type, 2021 (%)
- Direct Thrombin Inhibitor
- Factor Xa Inhibitors
Global Novel Oral Anticoagulants Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Novel Oral Anticoagulants Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Drugs Stores
- Other
Global Novel Oral Anticoagulants Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Novel Oral Anticoagulants Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Novel Oral Anticoagulants Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Novel Oral Anticoagulants Drugs revenues share in global market, 2021 (%)
- Key companies Novel Oral Anticoagulants Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Novel Oral Anticoagulants Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Bayer
- Pfizer
- Johnson & Johnson
- Boehringer Ingelheim
- Daiichi Sankyo
